about
Establishment and characterization of a novel uterine carcinosarcoma cell line, TU-ECS-1, with mutations of TP53 and KRAS.Durable complete remission with aromatase inhibitor therapy in a patient with metastatic uterine carcinosarcoma with poor performance status and coagulation disorders: a case reportPrognostic value of metabolic parameters determined by preoperative ¹⁸F-FDG PET/CT in patients with uterine carcinosarcoma.Delayed and clinically isolated port site carcinosarcoma recurrence as an early indicator of disseminated diseaseClinical Characteristics, Surgical Management and Adjuvant Therapy of Patients with Uterine Carcinosarcoma: A Retrospective Case Series.Pazopanib as a second line treatment for uterine and ovarian carcinosarcoma: a single institutional study.Significance of histologic pattern of carcinoma and sarcoma components on survival outcomes of uterine carcinosarcoma.Prognostic factors for disease-free and overall survival of patients with uterine carcinosarcoma.An update on the current pharmacotherapy for endometrial cancer.Distinct molecular landscapes between endometrioid and nonendometrioid uterine carcinomas.Genetic analysis of uterine aspirates improves the diagnostic value and captures the intra-tumor heterogeneity of endometrial cancers.Biphasic malignant tumours of the abdominal cavity.Uterine Cancer After Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With BRCA Mutations.Unenhanced region on magnetic resonance imaging represents tumor progression in uterine carcinosarcoma.Port-Site Metastasis of Uterine Carcinosarcoma after Laparoscopy.Survival outcome of women with stage IV uterine carcinosarcoma who received neoadjuvant chemotherapy followed by surgery.CNS metastasis secondary to malignant-mixed Müllerian tumor: case report and review of therapeutics.Trends of uterine carcinosarcoma in the United States.Carcinosarcoma of the uterus: MRI findings including diffusion-weighted imaging and MR spectroscopy.Targeted Therapies in Type II Endometrial Cancers: Too Little, but Not Too Late
P2860
Q33364318-F08B342E-63B0-406B-AD02-6907F3F44D16Q33582227-D5495243-E4FD-4AC7-BC9D-9448CCAF6E19Q33735128-F422AE67-278B-4096-AE78-5610D5BFA1B3Q36397682-AFBCA5D6-07FE-461B-8849-72A766754F73Q36631823-1209FBBD-C628-466A-9AF2-4140606118C9Q37512369-F7C6D4D6-C8EF-45E5-B7FE-C79DE1B2F732Q38381194-72304503-17EC-4578-99B7-805C37A8B52EQ38610976-D4F27FE1-F489-4E9E-9A4C-5B3F97184818Q38656675-2D0BF11E-5E4D-4F42-A1FF-BA0CBA3803DFQ38788729-62C0B4BC-D406-452D-A34B-5091730C8FF2Q38825241-03AB676C-14F4-4979-8B02-09BA6ED9D74BQ39401746-108CCCDB-DBE0-499D-8247-F94D67A85514Q39639274-86D1E574-BA72-4858-AEDC-820F64BC4732Q41218661-EF2B8845-E0BE-4B07-A5B1-14414B891760Q42702637-4F8DF1CF-8C19-4BE4-93FA-A2C4C0265AA7Q46221677-DADF68E6-BC1F-47F8-88DA-E1CA413EF713Q48027897-98A86DB7-BFD4-465A-92AB-AFABEE2A8483Q48107255-3504A740-6F55-49A3-ACBD-1EA214F16649Q53202984-6558AF48-9393-4B53-A0DB-18B8222409A7Q57169683-770F5E54-3FD5-4298-97A6-4DE410505AE4
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Uterine carcinosarcoma: A review of the literature.
@ast
Uterine carcinosarcoma: A review of the literature.
@en
type
label
Uterine carcinosarcoma: A review of the literature.
@ast
Uterine carcinosarcoma: A review of the literature.
@en
prefLabel
Uterine carcinosarcoma: A review of the literature.
@ast
Uterine carcinosarcoma: A review of the literature.
@en
P2093
P1433
P1476
Uterine carcinosarcoma: A review of the literature.
@en
P2093
Leigh A Cantrell
Linda R Duska
Stephanie V Blank
P304
P356
10.1016/J.YGYNO.2015.03.041
P407
P577
2015-03-21T00:00:00Z